BORIS GUZMÁN FERNÁNDEZ & col
526
de un grupo de compuestos analogos del acyclovir y ganciclovir. An. R. Acad. Nac. Farm
76(1), 45-‐57.
30.
Gálvez-‐Llompart M., Recio M.C., García-‐Domenech R. (2011) Topological virtual
screening: a way to find new compounds active in ulcerative colitis by inhibiting NF-‐κB.
Mol Divers 15(4), 917-‐26.
31.
Casabán-‐Ros E., Antón-‐Fos G.M., Gálvez J., et al. (1999) Search for New Antihistaminic
Compounds by Molecular Connectivity. Quant Struct-‐Act Relat 18, 35-‐42.
32.
Jasinski P., Welsh B., Galvez J., et al. (2008) A novel quinoline, MT477: Suppresses cell
signaling through ras molecular pathway, inhibits PKC activity, and demonstrates in
vivo anti-‐tumor activity against human carcinoma cell lines. Invest New Drugs
26(3),223-‐232.
33.
Jasinski P., Zwolak P., Isaksson V.R., et al. (2011) MT103 inhibits tumor growth with
minimal toxicity in murine model of lung carcinoma via induction of apoptosis. Invest
New Drugs 29(5),1-‐7.
34.
Galvez J., Llompart J., Land D., et al. (2010) Mount Sinai School of Medicine of New York
University, USA, Medisyn Technologies I, assignees. Compositions for treatment of
Alzheimer’s disease using Abeta-‐reducing and/or Abeta-‐anti-‐aggregation compounds.
WO/2010/114636; PCT/US2010/001041.
35.
Lutje V., Seixas J., Kennedy A.(2010) Chemoterapy for second-‐stage Human African
trypanosomiasis. Cochrane Database of Systematic Reviews. Issue 8. Art. No.:
CD006201. DOI:10.1002/14651858.CD006201.
36.
Bourdin B., Jedrysiak R., Tweats D., Brun R., Kaiser M., Suwinski J., Torreele E. (2011)1-‐
Aril-‐4-‐nitro-‐1H-‐imidazoles, a new promising series for the treatment of human African
trypanosomiasis. Eur J Med Chem 46, 1524-‐1535.
37.
Randic, M. (1975) On characterization of molecular branching. J Am Chem Soc 97, 6609-‐
6615.
38.
Kier L.B., Hall L.H. (1986) Molecular Connectivity in Structure-‐Activity Analysis.
Research Studies Press, Letchworth, UK.
39.
Gálvez J., García-‐Doménech R., Salabert M.T., Soler R. (1994) Charge Indices. New
topological descriptors. J Chem Inf Comput Sci 34, 520-‐525.
40.
Statistica (data analysis software system), version 9.0(2009) Statsoft: Tulsa, OK.
41.
Wold S., Eriksson L., Clementi S. (2008) Statistical validation of QSAR results, in
Chemometric Methods in Molecular Design (ed H. van de Waterbeemd), Wiley-‐VCH
Verlag GmbH, Weinheim, Germany. doi: 10.1002/9783527615452.ch5.
42.
Dixon W.J. (1990) BMDP statistical software manual: to accompany the 1990 software
release. Univ of California Pr; San Francisco.
43.
Roy P.P., Leonard J.T., Roy K. (2008) Exploring the impact of size of training sets for the
development of predictive QSAR models. Chem Intell Lab Syst 90(1), 31-‐42.
44.
Galvez J., Garcia-‐Domenech R., de Gregorio Alapont C., et al. (1996) Pharmacological
distribution diagrams: a tool for de novo drug design. J Mol Graph 14(5), 272-‐276.
45.
Lachenbruch P.A., Mickey M.R. (1968) Estimation of error rates in discriminant analysis.
Technometrics 10(1), 1-‐11.
